Vallet-Regí María, Colilla Montserrat, Izquierdo-Barba Isabel, Vitale-Brovarone Chiara, Fiorilli Sonia
Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12, 28040 Madrid, Spain.
CIBER de Bioingeniería Biomateriales y Nanomedicina CIBER-BBN, 28040 Madrid, Spain.
Pharmaceutics. 2022 Nov 29;14(12):2636. doi: 10.3390/pharmaceutics14122636.
Nowadays, mesoporous bioactive glasses (MBGs) are envisaged as promising candidates in the field of bioceramics for bone tissue regeneration. This is ascribed to their singular chemical composition, structural and textural properties and easy-to-functionalize surface, giving rise to accelerated bioactive responses and capacity for local drug delivery. Since their discovery at the beginning of the 21st century, pioneering research efforts focused on the design and fabrication of MBGs with optimal compositional, textural and structural properties to elicit superior bioactive behavior. The current trends conceive MBGs as multitherapy systems for the treatment of bone-related pathologies, emphasizing the need of fine-tuning surface functionalization. Herein, we focus on the recent developments in MBGs for biomedical applications. First, the role of MBGs in the design and fabrication of three-dimensional scaffolds that fulfil the highly demanding requirements for bone tissue engineering is outlined. The different approaches for developing multifunctional MBGs are overviewed, including the incorporation of therapeutic ions in the glass composition and the surface functionalization with zwitterionic moieties to prevent bacterial adhesion. The bourgeoning scientific literature on MBGs as local delivery systems of diverse therapeutic cargoes (osteogenic/antiosteoporotic, angiogenic, antibacterial, anti-inflammatory and antitumor agents) is addressed. Finally, the current challenges and future directions for the clinical translation of MBGs are discussed.
如今,介孔生物活性玻璃(MBGs)被视为生物陶瓷领域中用于骨组织再生的有前景的候选材料。这归因于它们独特的化学成分、结构和纹理特性以及易于功能化的表面,从而产生加速的生物活性反应和局部药物递送能力。自21世纪初被发现以来,开创性的研究工作集中在设计和制造具有最佳组成、纹理和结构特性的MBGs,以引发卓越的生物活性行为。当前的趋势将MBGs视为治疗骨相关疾病的多疗法系统,强调微调表面功能化的必要性。在此,我们关注MBGs在生物医学应用方面的最新进展。首先,概述了MBGs在设计和制造满足骨组织工程高要求的三维支架中的作用。综述了开发多功能MBGs的不同方法,包括在玻璃成分中引入治疗性离子以及用两性离子部分进行表面功能化以防止细菌粘附。阐述了关于MBGs作为多种治疗药物(成骨/抗骨质疏松、血管生成、抗菌、抗炎和抗肿瘤药物)局部递送系统的新兴科学文献。最后,讨论了MBGs临床转化的当前挑战和未来方向。